Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04335695 · ClinicalTrials.gov registry record · NA
Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04335695: Clinical Trial NA study, sponsored by Baylor Research Institute.
NCT04335695 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04335695, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the type of patients being referred for the Vascular Rehabilitation Program (VRP) and to study the success rates of the program according to improvements in walking distance and quality of life surveys. Subjects will be in the VRP for 6-12 weeks and then be followed for 12 months after they complete the program. This is a single-site study at Baylor Scott \& White Heart Hospital-Plano.
Primary Outcome
ABI will be obtained according to standard practice. Severe disease= \<=0.4; Mild to moderate disease= 0.41-0.9; Normal= \>1.0
Interventions
- BEHAVIORAL Vascular Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-12-13 |
| Est. Completion | 2022-01-24 |
| Phase | NA |
Why NCT04335695 stopped before completion
NCT04335695 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Vascular Rehabilitation is the first listed.
NCT04335695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04335695 about?
NCT04335695 is a clinical study titled "Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life". The purpose of this study is to identify the type of patients being referred for the Vascular Rehabilitation Program (VRP) and to study the success rates of the program according to improvements in walking distance and quality of life surveys. Subjects will be in the VRP for 6-12 weeks and then be f...
What is the current status of trial NCT04335695?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2019-12-13. Estimated completion is 2022-01-24.
What interventions are being tested in trial NCT04335695?
The interventions under investigation include: Vascular Rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04335695?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04335695's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI